We are open as normal during COVID-19 pandemic. Order online, same day shipping out from North Carolina, USA
WARNING: This product is for research use only, not for human or veterinary use.
Bcr-Abl-IN-Y9 is a novel Bcr-Abl inhibitor, potently inhibited Bcr-AblWT and Bcr-AblT315I kinases with IC50 of 0.043 μM and 0.17 μM, respectively.
Price and Availability
Pricing updated 2020-10-29.
Prices are subject to change without notice.
Bcr-Abl-IN-Y9 is not in stock, may be available through custom synthesis. For cost-effective reason, minimum 1 gram order is requested. The product will be characterized by NMR, HPLC and MS analysis. Purity (HPLC) is usually >98%. CoA, QC data, MSDS will be provided when product is successfully made. The estimated lead time is 2-3 months. Please send email to firstname.lastname@example.org to inquire quote.
MedKoo Cat#: 533251
Chemical Formula: C19H22N4O4S
Exact Mass: 402.1362
Molecular Weight: 402.469
Elemental Analysis: C, 56.70; H, 5.51; N, 13.92; O, 15.90; S, 7.97